Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05630040 · ClinicalTrials.gov registry record · NA
VNS for Long-COVID-19
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05630040 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 40 participants.
The verdict
NCT05630040, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this proposed clinical case series is to evaluate the effect of a non-invasive vagus nerve stimulation paradigm on: 1) Symptom reporting via validated patient reported outcomes, and 2) objective clinical biomarkers of autonomic nervous system function. This will be a placebo controlled, randomized controlled trial with a crossover design built in. This study will aim to recruit 40 people with Long COVID to be a part of this research.
Interventions
- DEVICE Sham Intervention
- DEVICE Non-invasive vagus nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2024-10-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05630040
The ClinicalTrials.gov registry entry for NCT05630040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Intervention is the first listed.
NCT05630040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05630040 about?
NCT05630040 is a clinical study titled "VNS for Long-COVID-19". The goal of this proposed clinical case series is to evaluate the effect of a non-invasive vagus nerve stimulation paradigm on: 1) Symptom reporting via validated patient reported outcomes, and 2) objective clinical biomarkers of autonomic nervous system function. This will be a placebo controlled,...
What is the current status of trial NCT05630040?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-11-11. Estimated completion is 2024-10-03.
What interventions are being tested in trial NCT05630040?
The interventions under investigation include: Sham Intervention (DEVICE), Non-invasive vagus nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT05630040?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.